Patients with type 2 diabetes often experience fatigue, which impacts their self-care and quality of life. There are few data supporting a relationship between fatigue and glucose homeostasis, but fatigue in type 2 diabetes has been associated with higher body mass index (BMI), depression, physical inactivity, sleep disturbances, and chronic low-grade inflammation. Although links between fatigue and inflammation are documented in other disease populations, little is known about inflammatory mechanisms specific to type 2 diabetes and associated treatment modalities for type 2 diabetes-related fatigue. Herein we review existing knowledge about fatigue in type 2 diabetes and potential pharmacologic and behavioral therapies.
sleep disturbances, 1, 15, 16 and elevated cytokines. 3, 10 Fritschi and Quinn recently provided a detailed review of the correlates of fatigue in diabetes, including conflicting findings regarding the relationship between fatigue and glycemic control. 8 Type 2 diabetes is a disorder associated with chronic low-grade inflammation. 17, 18 Type 2 diabetes and insulin resistance, especially among obese patients, were linked to an increased production of cytokines and CRP were associated with high fatigue levels 10, 11, 19, 20 and depression and sleep disturbances in a variety of diseases. [21] [22] [23] [24] There is a considerable gap in the literature, however, about the treatment of fatigue secondary to type 2 diabetes. Anti-inflammatory therapies may ameliorate fatigue with type 2 diabetes. Thus, our discussion of fatigue interventions will focus on the few available pharmacologic and behavioral interventions in patients with type 2 diabetes to impact inflammation and fatigue.
Pharmacologic Therapy
Pharmacologic fatigue therapies are in their infancy. The primary therapeutic target has been reducing symptoms of fatigue, depression, and pain associated with high levels of pro-inflammatory cytokines. higher risk for infection, and the long-term benefits are unknown.
In the place of available pharmacologic agents, several behavioral therapies were been associated with reductions in fatigue levels and we discuss these below.
Weight Reduction and Dietary Changes
Fatigue was strongly associated with increased BMI and obesity in both the general population [29] [30] [31] and patients with type 2 diabetes. 7, 32, 33 Obesity was also correlated with inflammation; however, the data were conflicting about:
• the temporal relationship between obesity, inflammation, and fatigue;
• the type of fat (visceral versus subcutaneous) with the most influence on inflammation and fatigue; and
• whether pro-inflammatory cytokines mediate the effects of obesity on fatigue levels or if obesity is the causal factor in fatigue. [34] [35] [36] Whether through reduction in inflammation or simply reduction in fat mass, evidence supports the fatigue-reducing effects of weight loss.
Longitudinal data from the Bypass Angioplasty Revascularization Investigation 2 Diabetes Trial (BARI 2D) of 2,163 patients with diabetes and stable ischemic heart disease who were obese at baseline revealed significant improvements in functional capacity and feelings of energy through weight reduction. 33 High dietary fat-induced obesity has been associated with greater levels of low-grade inflammation, especially increased IL-6 and TNF-α. 37 Dietary interventions successfully reduced obesity and inflammation, but few investigators measured the concurrent influences on fatigue. A recent study compared the effects on measures of inflammation, BMI and glycemia of a low glycemic index (LGI) diet to a high glycemic index (HGI) diet plus aerobic exercise in obese, insulin-resistant adults. 38 Both interventions resulted in decreased BMI and fasting plasma glucose and insulin levels. Only the LGI diet group had decreased plasma TNF-α, MCP-1, and IL-6 compared to baseline. These data suggest that an LGI diet may have the benefits of both improved glycemic control and a reduction in systemic inflammation in patients with type 2 diabetes. 38 In a secondary analysis of data from the NHANES cohort, King reported that adults who were obese, had hypertension or diabetes, and consumed high dietary fiber (> 20 g/day) had significantly lower levels of CRP than did those adults who consumed lower fiber. 39 Similarly, Esposito conducted a study of 120 obese, healthy, pre-menopausal women. Half the group was assigned to a reduced-calorie Mediterranean-style diet and exercise and a control group received healthy lifestyle information only. Women in the intervention group consumed fewer calories, less saturated fat and cholesterol, and more high-complex carbohydrates, fiber and mono-unsaturated fats compared to the control group.
After two years, women in the intervention group demonstrated a significantly greater weight loss and lower insulin resistance compared to those in the control group. In addition, serum pro-inflammatory cytokine levels IL-6 and IL-18 decreased significantly in the intervention group compared to controls. 40 Decreased serum CRP was also measured in adults over age 60 who ate a diet high in omega 3 fatty acids for eight weeks 41 and in adults with type 2 diabetes and nephropathy who replaced 50 % of their meat protein intake with soy protein. 42 The same authors reported a linear relationship between consumption of red meat and increased risks for metabolic syndrome and inflammation. 43 Modest caloric restriction was also shown to reduce systemic inflammation over time. 44, 45 For example, Khoo et al. randomized men with type 2 diabetes to an eight-week very low calorie diet (approximately 1,000 kcal/day) or to a low-fat, low-carbohydrate, high-protein diet (prescribed to reduce intake by approximately 600 kcal/day compared to their usual diet); after eight-weeks all subjects followed the latter diet for another 44 weeks. Interestingly, upon conclusion of the study, only subjects originally assigned to the high-protein, low-fat, low-carbohydrate diet had decreased CRP and IL-6 compared to baseline levels, and significant reductions in these inflammatory molecules were still evident one year later. 44 Both groups, however, experienced significant reductions in weight and blood glucose. In another study, Snel et al.
measured the long-term effects of a four-month very low calorie diet with exercise in obese men and women with type 2 diabetes. Although subjects experienced weight loss, there were no significant changes in pro-inflammatory cytokines upon the conclusion of the intervention. At six-month follow-up (after weight loss when subjects resumed a eucaloric diet), however, plasma levels of CRP, interferon-γ (INF-γ), IL-1, IL-2, IL-6, IL-8
and TNF-α were all significantly decreased compared to baseline. 45 Collectively, the above findings indicate that weight loss, increased consumption of fiber, omega 3 fatty acids and vegetable-based proteins, with reductions in saturated fats and calories may help to reduce low-grade inflammation and some of its associated sickness behaviors, including fatigue. More extreme caloric restriction, however, does not appear to have a beneficial effect on cytokine profiles despite weight loss.
Improved Sleep
Sleep disturbances, including obstructive sleep apnea (OSA) and disrupted sleep due to restless leg syndrome, nocturia, and pain are common in type 2 diabetes and have been associated with a variety of sickness behaviors, including depressed mood, reduced physical activity, excessive daytime sleepiness, and fatigue. [46] [47] [48] [49] Disturbed sleep has been associated with both poor glucose control [50] [51] [52] and obesity.
Again, the temporal nature of these relationships has yet to be elucidated; however, there is strong evidence that these phenomena explain only part of sleep issues and are all intertwined with low-grade, systemic inflammation. 21, 22, 34, 53, 54 Sleep disturbances, while common in type 2 diabetes, often go undetected. Prevention of nocturia-induced awakenings through improved glycemic control is the starting point for improving sleep and thus fatigue in type 2 diabetes. In patients with OSA and type 2 diabetes, use of continuous positive airway pressure (CPAP) treatment has been associated with improved sleep parameters, as well as improved glycemic control, 55, 56 which may affect subjective fatigue levels. Bardwell reported that, in patients with OSA, higher levels of depressive symptoms predicted higher fatigue, even after controlling for the OSA, 57 while Hong reported that low physical activity predicted fatigue better than OSA after controlling for BMI in obese individuals. 58 In summary, disturbed sleep is common among patients with type 2 diabetes and may affect fatigue levels either directly or indirectly through higher levels of inflammation alone, or in congruence with obesity, depression, poor glucose control, or physical inactivity. 
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